BioStem Technologies gains four U.S. design patents for placental allograft technology

Patent Expiryplacental allograftPositive

AI Analysis

Summary

BioStem Technologies obtained four U.S. design patents for its placental allograft technology, strengthening its intellectual property portfolio in regenerative medicine.

Outcome Details

Four U.S. design patents granted

Importance:3/10

Sentiment:

0.60

patentintellectual propertyplacental allograftdesign patent

Related Companies

$BSEM

Read the original article

Published by Seeking Alpha Healthcare on July 8, 2026 12:49 PM

Read Original